Concepedia

Author

Ashley B. Boam

Center for Drug Evaluation and ResearchORCID

Also Known As

Ashley B Boam, Ashley B. Boam, Ashley Boam, M. Berenger

15

Publications

5.9K

Citations

9

H-Index

35

Concepts

All Affiliations

Center for Drug Evaluation and ResearchPfizer (United States)United States Food and Drug AdministrationCenter for Devices and Radiological HealthTeva Pharmaceuticals (United States)
AB

About

Ashley B. Boam is an author at Center for Drug Evaluation and Research specializing in health policy, engineering, and marketing.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

3

3

104

2

Medicine

2

2

297

3

Public Health

2

2

302

4

Business

1

1

54

5

Education

1

1

38

Ashley B. Boam

×

7

Publications

5.8K

Citations

7

H-Index

YearCitations

Clinical End Points in Coronary Stent Trials

Donald E. Cutlip, Stephan Windecker, Roxana Mehran,

Circulation

2007

5.4K

Stent Thrombosis Redux — The FDA Perspective

Andrew Farb, Ashley B. Boam

New England Journal of Medicine

2007

283

An audit of pharmaceutical continuous manufacturing regulatory submissions and outcomes in the US

Adam C. Fisher, William Liu, Andreas Schick,

International Journal of Pharmaceutics

2022

54

The Academic Research Consortium Governance Charter

Mitchell W. Krucoff, Roxana Mehran, Gerrit‐Anne van Es,

JACC: Cardiovascular Interventions

2011

38

Advancing Product Quality: a Summary of the Second FDA/PQRI Conference

Lawrence X. Yu, Ilgaz Akseli, Barbara Allen,

The AAPS Journal

2016

31

Advancing Product Quality: a Summary of the Inaugural FDA/PQRI Conference

Lawrence X. Yu, Jeffrey C. Baker, Susan C. Berlam,

The AAPS Journal

2015

19

Coronary drug-eluting stent development: Issues in trial design

Neal I. Muni, Robert M. Califf, Jonette R. Foy,

American Heart Journal

2005

14

Page 1